Zycortal® Suspension (desoxycorticosterone pivalate injectable suspension)
For use in: Dogs only
ZYCORTAL Suspension is given subcutaneously as replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (Addison’s disease)
| Active(s)/Ingredient(s): | Desoxycorticosterone pivalate |
| Pack size(s): | 4ml |
| Documents: | Package insert get_app SDS get_app |
Important safety information
As with all drugs, side effects may occur. In field studies and post‐approval experience, the most common side effects reported were: polyuria, polydipsia, depression/lethargy, pain on injection, weight gain, inappropriate urination, alopecia, decreased appetite/anorexia, panting, vomiting, diarrhea, shaking/trembling, polyphagia, urinary tract infection, urinary tract incontinence, anaphylaxis, anemia, restlessness and collapse. Death or euthanasia has been associated with some of the adverse events listed above. ZYCORTAL Suspension should be used with caution in dogs with congestive heart disease, edema, severe renal disease or primary hepatic failure. Dogs presenting in Addisonian crisis must be rehydrated with appropriate intravenous therapy before starting treatment with ZYCORTAL Suspension. Refer to the prescribing information for complete details or visit www.dechra‐us.com.
